unknown
Stage
2
Investors
About
Immuneel Therapeutics is an Indian biopharmaceutical company developing and commercializing cell, gene, and immunotherapies for cancer. It has commercialized Qartemi (varnimcabtagene autoleucel), an autologous CD19 CAR-T therapy for relapsed and refractory non-Hodgkin's lymphoma in India.
Explore Immuneel Therapeutics Private Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.